Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thymoma × alovudine × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphatic Metastasis 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms, Male 1 Anus Neoplasms 1

Interventions

Taxes 2 Sunitinib 2 Paclitaxel 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Carboplatin 2 vorolanib 1 selinexor 1 saracatinib 1 pembrolizumab 1 epacadostat 1 belinostat 1 amrubicin 1 Thymectomy 1 Robotic Surgical Procedures 1 Ramucirumab 1 Prednisone 1 Prednisolone 1 Pemetrexed 1 Nivolumab 1 NVP-BKM120 1 MK 2206 1 Lapatinib 1 Fentanyl 1 Erlotinib Hydrochloride 1 Doxepin 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡